Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Metabolic Dysfunction-Associated Fibrosis Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

van Kleef, Laurens A; Francque, Sven M; Prieto-Ortiz, Jhon E; Sonneveld, Milan J; Sanchez-Luque, Carlos B; Prieto-Ortiz, Robin G; Kwanten, Wilhelmus J; Vonghia, Luisa; Verrijken, An; De Block, Christophe; Gadi, Zouhir; Janssen, Harry L A; de Knegt, Robert J; Brouwer, Willem P.

Gastroenterology ; 2024 Mar 19.

Artigo em Inglês | MEDLINE | ID: mdl-38513745

2.

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(3): 942-948, 2023 03 01.

Artigo em Inglês | MEDLINE | ID: mdl-35776631

3.

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study.

van Kleef, Laurens A; Sonneveld, Milan J; Kavousi, Maryam; Ikram, M Arfan; de Man, Robert A; de Knegt, Robert J.

Hepatology ; 77(2): 585-593, 2023 02 01.

Artigo em Inglês | MEDLINE | ID: mdl-35753042

4.

Plasma proteomic signature of fatty liver disease: The Rotterdam Study.

Abozaid, Yasir J; Ayada, Ibrahim; van Kleef, Laurens A; Vallerga, Costanza L; Pan, Qiuwei; Brouwer, Willem P; Ikram, M Arfan; Van Meurs, Joyce; de Knegt, Robert J; Ghanbari, Mohsen.

Hepatology ; 78(1): 284-294, 2023 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-36738080

5.

Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.

Patmore, Lesley A; Katwaroe, Warshan K; van der Spek, Daniel; Choi, Hannah S J; Patel, Keyur; Brakenhoff, Sylvia; van der Meer, Adriaan J; Brouwer, Willem P; van Kleef, Laurens A; de Knegt, Rob J; Hansen, Bettina E; de Man, Rob A; Feld, Jordan J; Janssen, Harry L A; Sonneveld, Milan J.

Clin Gastroenterol Hepatol ; 21(12): 3089-3096.e1, 2023 11.

Artigo em Inglês | MEDLINE | ID: mdl-37004973

6.

Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.

van Kleef, Laurens A; Ayada, Ibrahim; Alferink, Louise J M; Pan, Qiuwei; de Knegt, Robert J.

Hepatology ; 75(2): 419-429, 2022 02.

Artigo em Inglês | MEDLINE | ID: mdl-34453359

7.

Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study.

van Kleef, Laurens A; Sonneveld, Milan J; Zhu, Fang; Ikram, M Arfan; Kavousi, Maryam; de Knegt, Robert J.

Liver Int ; 43(5): 1000-1007, 2023 05.

Artigo em Inglês | MEDLINE | ID: mdl-36744819

8.

Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study.

van Kleef, Laurens A; Lu, Zuolin; Ikram, M Arfan; de Groot, Natasja M S; Kavousi, Maryam; de Knegt, Robert J.

J Hepatol ; 77(4): 931-938, 2022 10.

Artigo em Inglês | MEDLINE | ID: mdl-35688226

9.

Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.

van Kleef, Laurens A; Hofman, Amy; Voortman, Trudy; de Knegt, Robert J.

Am J Gastroenterol ; 117(2): 311-318, 2022 02 01.

Artigo em Inglês | MEDLINE | ID: mdl-34904966

10.

Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups.

Ayada, Ibrahim; van Kleef, Laurens A; Alferink, Louise J M; Li, Pengfei; de Knegt, Robert J; Pan, Qiuwei.

Liver Int ; 42(2): 277-287, 2022 02.

Artigo em Inglês | MEDLINE | ID: mdl-34953098

11.

Reply.

van Kleef, Laurens A; Sonneveld, Milan J; de Knegt, Robert J.

Hepatology ; 77(3): E41-E42, 2023 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-35862439

12.

Reply: Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations.

van Kleef, Laurens A; Sonneveld, Milan J; de Knegt, Robert J.

Hepatology ; 78(2): E31-E32, 2023 08 01.

Artigo em Inglês | MEDLINE | ID: mdl-37162158

13.

Reply.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(4): E69-E70, 2023 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-36054493

14.

Reply.

van Kleef, Laurens A; Sonneveld, Milan J; de Knegt, Robert J.

Hepatology ; 77(3): E49-E50, 2023 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-36056811

15.

Reply.

van Kleef, Laurens A; Sonneveld, Milan J; de Knegt, Robert J.

Hepatology ; 77(2): E30-E31, 2023 Feb 01.

Artigo em Inglês | MEDLINE | ID: mdl-36056819

16.

Reply.

van Kleef, Laurens A; de Knegt, Robert J; Brouwer, Willem Pieter.

Hepatology ; 77(3): E45-E46, 2023 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-36057078

17.

Modifiable risk factors for fatty liver disease: Time to act.

van Kleef, Laurens A; de Knegt, Robert J.

Hepatology ; 77(3): 712-714, 2023 03 01.

Artigo em Inglês | MEDLINE | ID: mdl-36114010

18.

Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?

Van Kleef, Laurens A; Ayada, Ibrahim; de Knegt, Robert J.

Clin Gastroenterol Hepatol ; 21(3): 849, 2023 03.

Artigo em Inglês | MEDLINE | ID: mdl-35483603

19.

Does NAFLD Prevalence Data Expire?

Van Kleef, Laurens A; Ayada, Ibrahim; De Knegt, Robert J.

Clin Gastroenterol Hepatol ; 21(2): 555, 2023 02.

Artigo em Inglês | MEDLINE | ID: mdl-35276327

20.

Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.

van Kleef, Laurens A; Sonneveld, Milan J; de Knegt, Robert J.

Clin Gastroenterol Hepatol ; 21(1): 238-239, 2023 01.

Artigo em Inglês | MEDLINE | ID: mdl-35151862

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Metabolic Dysfunction-Associated Fibrosis Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study.

Plasma proteomic signature of fatty liver disease: The Rotterdam Study.

Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.

Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.

Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study.

Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study.

Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.

Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups.

Reply.

Reply: Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations.

Reply.

Reply.

Reply.

Reply.

Modifiable risk factors for fatty liver disease: Time to act.

Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?

Does NAFLD Prevalence Data Expire?

Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.